In the realm of rare disease research, collaboration across disciplines, organization types, and disease types is essential to accelerating progress. Traditionally, scientists have focused on studying individual rare diseases within their specific silos, but as the understanding of genetic, molecular, and therapeutic commonalities across diseases deepens, researchers are increasingly looking to connect and share insights with those studying different rare conditions. By forming cross-disease communities,